Malaria Consortium is delighted to have been named a GiveWell top charity for our seasonal malaria chemoprevention programme for a second year running.
GiveWell is a non-profit dedicated to finding outstanding giving opportunities and publishing the full details of their analysis to help donors decide where to give. GiveWell recommends charities by assessing them on four criteria: evidence of effectiveness, cost-effectiveness, transparency, and how much good they can accomplish with additional dollars. In order for any charity to receive a GiveWell recommendation, it must undergo a rigorous and extensive assessment process. GiveWell stated that Malaria Consortium’s seasonal malaria chemoprevention programme is “an organization that we feel offers donors an outstanding opportunity to accomplish good with their donations."
Through our expertise in delivering seasonal malaria chemoprevention (SMC) programmes, our progress in eliminating malaria has been recognised as among the most effective worldwide. SMC is a highly effective intervention providing protection for children under five living in areas of the Sahel, who are the most vulnerable to the disease. SMC involves administering up to four monthly doses of preventive antimalarial drugs to children aged three to 59 months during peak malaria transmission in the rainy season. Since it was approved by the World Health Organization in 2012, SMC has been found to prevent 75 percent or more of malaria cases.
We built up our expertise in SMC thanks to our ACCESS-SMC project which has been focusing on helping national malaria control programmes in seven countries to scale up SMC coverage, providing technical, logistical and financial support. We bring extensive experience and tested models of delivery, of strengthening national drug supply chains, and supporting delivery of SMC to beneficiaries.
We are very pleased to have received this recognition of excellence for a second year, and for the generous grant from the Open Philanthropy Project of $27.9 million. This grant will allow Malaria Consortium to close gaps in SMC coverage over three years and support about 3.5 million children under five in Nigeria, Burkina Faso and Chad.